Repetitive transcranial magnetic stimulation to the right dorsomedial prefrontal cortex and dorsolateral prefrontal cortex for treatment of post-traumatic stress disorder: A sham lead-in randomized controlled trial: Stimulation magnétique transcrânie

Objective In Canada, lifetime prevalence of post-traumatic stress disorder (PTSD) is as high as 9.2%. The use of repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (DLPFC) for PTSD has demonstrated promise; however, large placebo responses to sham rTMS have limited interpretation and, as such, definitive trials are required. One hypothesis suggests treatments for PTSD may require more specific neuromodulation target sites, such as the dorsomedial prefrontal cortex (DMPFC). The primary aim of this study was to compare PTSD symptom severity following a sham lead-in followed by rTMS targeting the right DLPFC or right DMPFC in patients with clinically diagnosed PTSD. Methods In this sham lead-in randomized controlled trial, participants with clinician-diagnosed PTSD were randomized to rTMS targeting the right DLPFC or DMPFC. The sham lead-in consisted of five sessions followed by 20 daily sessions of active-rTMS at 1 Hz for 1500 pulses at 100–120% of resting motor threshold. The primary outcome was the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), and secondary measures included depression, anxiety, quality of life, and cognition. Results We recruited 25 adults with PTSD. Following sham lead-in, there was a significant improvement in CAPS-5 (−12.8, 95% CI [−17.0, −8.7], p < .001) and all secondary outcomes other than quality of life and cognition. Improvements were maintained following active rTMS in both DLPFC and DMPFC groups; however, the change in score following active rTMS did not produce meaningful benefits beyond the initial placebo response, nor were there any differences between the DLPFC and DMPFC treatment locations for the CAPS-5. Conclusions Following sham lead-in, all outcome measures other than cognition and quality of life improved, indicating a significant placebo response in this patient population. There were no differences when comparing response to sham lead-in and active rTMS or when comparing treatment response at either location (DLPFC vs DMPFC). Plain Language Summary Exploring repetitive transcranial magnetic stimulation at two different treatment sites for Post Traumatic Stress Disorder Why was this study done? Up to 9.2% of Canadians experience post traumatic stress disorder (PTSD) within their lifetime. Repetitive transcranial magnetic stimulation (rTMS) is a treatment where magnetic pulses are delivered to the head to change brain activity and has shown promise as a treatment for PTSD. However, there is limited evidence which shows that rTMS is better than inactive or “sham” rTMS. One reason for this might be that we need to try rTMS at different brain locations. The aim of this study was to compare rTMS at two different treatment locations after one week of sham rTMS. What did the researchers do? The researchers recruited 25 adult participants with diagnosed PTSD who took part in five daily sham rTMS sessions followed by 20 real or “active” rTMS sessions at one of two treatment locations, the dorsolateral prefrontal cortex and dorsomedial prefrontal cortex. They assessed the participants' PTSD symptoms, mood, quality of life, and thinking skills at the start of the study, after the sham rTMS, and after the active rTMS. What did the researchers find? After the sham rTMS, there was a large improvement in all the assessments other than quality of life and thinking. These improvements continued after the active rTMS treatment at both sites. However, there were no differences between the sham or the active rTMS or between the two treatment sites. What do the findings mean? Participants improved following sham rTMS treatment, showing a “placebo” response. Participants did get better throughout the trial, but we can't say this was due to the active rTMS being better than the sham rTMS or that one location was better than the other.

Authors

Institutions

Publication Details

Journal
The Canadian Journal of Psychiatry
Published
2026-11-17
DOI
https://doi.org/10.1177/07067437261505218
Primary Topic
Transcranial Magnetic Stimulation Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Repetitive transcranial magnetic stimulation to the right dorsomedial prefrontal cortex and dorsolateral prefrontal cortex for treatment of post-traumatic stress disorder: A sham lead-in randomized controlled trial: Stimulation magnétique transcrânie

Regan King, Jason Tabor, Alexander McGirr, Frank P. MacMaster et al.
The Canadian Journal of Psychiatry
Transcranial Magnetic Stimulation Studies
article

Repetitive transcranial magnetic stimulation to the right dorsomedial prefrontal cortex and dorsolateral prefrontal cortex for treatment of post-traumatic stress disorder: A sham lead-in randomized controlled trial: Stimulation magnétique transcrânie

Regan King, Jason Tabor, Alexander McGirr, Frank P. MacMaster, Chantel Teresa Debert, Ashley D. Harris, Liu Shi Gan, Christina Campbell, Alison Janelle Wilson, Shannon Tabor
article en

Abstract

Objective In Canada, lifetime prevalence of post-traumatic stress disorder (PTSD) is as high as 9.2%. The use of repetitive transcranial magnetic stimulation (rTMS) targeting the dorsolateral prefrontal cortex (DLPFC) for PTSD has demonstrated promise; however, large placebo responses to sham rTMS have limited interpretation and, as such, definitive trials are required. One hypothesis suggests treatments for PTSD may require more specific neuromodulation target sites, such as the dorsomedial prefrontal cortex (DMPFC). The primary aim of this study was to compare PTSD symptom severity following a sham lead-in followed by rTMS targeting the right DLPFC or right DMPFC in patients with clinically diagnosed PTSD. Methods In this sham lead-in randomized controlled trial, participants with clinician-diagnosed PTSD were randomized to rTMS targeting the right DLPFC or DMPFC. The sham lead-in consisted of five sessions followed by 20 daily sessions of active-rTMS at 1 Hz for 1500 pulses at 100–120% of resting motor threshold. The primary outcome was the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), and secondary measures included depression, anxiety, quality of life, and cognition. Results We recruited 25 adults with PTSD. Following sham lead-in, there was a significant improvement in CAPS-5 (−12.8, 95% CI [−17.0, −8.7], p < .001) and all secondary outcomes other than quality of life and cognition. Improvements were maintained following active rTMS in both DLPFC and DMPFC groups; however, the change in score following active rTMS did not produce meaningful benefits beyond the initial placebo response, nor were there any differences between the DLPFC and DMPFC treatment locations for the CAPS-5. Conclusions Following sham lead-in, all outcome measures other than cognition and quality of life improved, indicating a significant placebo response in this patient population. There were no differences when comparing response to sham lead-in and active rTMS or when comparing treatment response at either location (DLPFC vs DMPFC). Plain Language Summary Exploring repetitive transcranial magnetic stimulation at two different treatment sites for Post Traumatic Stress Disorder Why was this study done? Up to 9.2% of Canadians experience post traumatic stress disorder (PTSD) within their lifetime. Repetitive transcranial magnetic stimulation (rTMS) is a treatment where magnetic pulses are delivered to the head to change brain activity and has shown promise as a treatment for PTSD. However, there is limited evidence which shows that rTMS is better than inactive or “sham” rTMS. One reason for this might be that we need to try rTMS at different brain locations. The aim of this study was to compare rTMS at two different treatment locations after one week of sham rTMS. What did the researchers do? The researchers recruited 25 adult participants with diagnosed PTSD who took part in five daily sham rTMS sessions followed by 20 real or “active” rTMS sessions at one of two treatment locations, the dorsolateral prefrontal cortex and dorsomedial prefrontal cortex. They assessed the participants' PTSD symptoms, mood, quality of life, and thinking skills at the start of the study, after the sham rTMS, and after the active rTMS. What did the researchers find? After the sham rTMS, there was a large improvement in all the assessments other than quality of life and thinking. These improvements continued after the active rTMS treatment at both sites. However, there were no differences between the sham or the active rTMS or between the two treatment sites. What do the findings mean? Participants improved following sham rTMS treatment, showing a “placebo” response. Participants did get better throughout the trial, but we can't say this was due to the active rTMS being better than the sham rTMS or that one location was better than the other.

The Canadian Journal of Psychiatry
Dalhousie University (CA), Centre for Addiction and Mental Health (CA), University of Calgary (CA), Izaak Walton Killam Health Centre (CA), Hotchkiss Brain Institute (CA), Mathison Centre for Mental Health Research and Education (CA)
Good health and well-being
Transcranial Magnetic Stimulation Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon